Emerging Global Leader Award (K43 Independent Clinical Trial Required)

This is a reissue of the Emerging Global Leader Program (K43) to align with the clinical trials policy. Eligibility: Other Eligible Applicants include the following: Non-domestic (non-U.S.) Entities (Foreign Organizations); Applications for the K43 award must be submitted by academic education or research institutions in LMICs (as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-lending-groups; low-income, lower-middle-income, and upper-middle-income countries are included). FIC's Country Eligibility Notice (NOT-TW-12-011 Notice of Change in Country Eligibility for Fogarty International Training Grants ) applies to this NOFO and states that for competing and re-competing research training grant applications (including the K43 mechanism), with the exception of Sub-Saharan African countries, FIC will no longer accept applications from, or applications that involve training of scientists from upper-middle-income countries that are also members of the G20 major economies (http://www.g20.org/en/members). For additional information see FIC's Country Eligibility page at https://www.fic.nih.gov/Grants/Pages/country-eligibility.aspx. Only non-domestic (non-U.S.) Entities (Foreign Institutions) in Low- or Middle-Income Countries are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.

CFDA number(s): 93.113

Federal funding opportunity published on Grants.gov. Applications are submitted through Grants.gov — see the official listing.